Opko Health Inc (OPK)

$1.35 -0.02 (-1.46%)
Market Cap 1.02B
Revenue (ttm) 713.14M
Net Income (ttm) -53.22M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7.46%
Debt to Equity Ratio 0.19
Volume 1,282,000
Avg Vol 2,248,484
Day's Range N/A - N/A
Shares Out 767.70M
Stochastic %K 75%
Beta 1.34
Analysts Strong Sell
Price Target $2.57

Company Profile

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 305 575 4100
Address:
4400 Biscayne Boulevard, Miami, United States
Iightning
Iightning Dec. 5 at 5:22 AM
1ightning® Premium Options Alert (Actionable) Ticker: $OPK Contract: Dec 19 $0.5C Entry: 0.90 Exit: 1.54 Return: +70.81% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 4 at 11:10 PM
1ightning® Premium Options Alert (Actionable) Ticker: $OPK Contract: Dec 19 $0.5C Entry: 0.90 Exit: 1.54 Return: +70.81% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
magadog
magadog Dec. 4 at 8:42 PM
$OPK I predict they will find sone way to restructure the co, sell pieces or all and give the shareholders pennies on the dollar
0 · Reply
Sierradude
Sierradude Dec. 4 at 3:00 PM
$OPK So much for the bullshit presentation. I seriously wonder what the floor is for the tutes to bail? Just get this POS to 2 and I'll take the loss and move on. Dead money for years. Will be interesting to see the market response when the old man croaks.
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 4 at 1:10 PM
$OPK 4 markets last mesage
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 4 at 1:10 PM
$OPK need this 1.35 *
0 · Reply
Mike18181
Mike18181 Dec. 4 at 12:56 PM
$OPK Stock will do " Norhing", the Mirage continues. Stocks rise on earnings. Not buying, by Frost Mirage or buyback mirage. Do you know what a Mirage is ? Do you ? That puddle of water is not really there. And Opko is really casfflow broke. This is why they sold assets to GET CASH. Because they cant retain any !
0 · Reply
Iightning
Iightning Dec. 4 at 6:50 AM
1ightning® Premium Options Alert (Actionable) Ticker: $OPK Contract: Dec 19 $0.5C Entry: 0.90 Exit: 1.70 Return: +88.76% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
magadog
magadog Dec. 3 at 9:00 PM
$OPK
0 · Reply
tradertrash
tradertrash Dec. 3 at 6:51 PM
$OPK annouce a buyback over a year ago, then dilution,
0 · Reply
Latest News on OPK
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 19, 2025, 4:05 PM EST - 15 days ago

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

OPKO Health, Inc. (OPK) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 9:36 PM EDT - 5 weeks ago

OPKO Health, Inc. (OPK) Q3 2025 Earnings Call Transcript

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results

Oct 29, 2025, 4:05 PM EDT - 5 weeks ago

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results

OPKO Health to Report Third Quarter 2025 Financial Results on October 29

Oct 22, 2025, 4:05 PM EDT - 6 weeks ago

OPKO Health to Report Third Quarter 2025 Financial Results on October 29

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Sep 15, 2025, 8:30 AM EDT - 2 months ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

LH

Opko Health (OPK) Q2 Revenue Falls 14%

Aug 1, 2025, 4:38 PM EDT - 4 months ago

Opko Health (OPK) Q2 Revenue Falls 14%

OPKO Health, Inc. (OPK) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 9:19 PM EDT - 4 months ago

OPKO Health, Inc. (OPK) Q2 2025 Earnings Call Transcript

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

Jul 31, 2025, 4:05 PM EDT - 4 months ago

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

NextPlat Issues Interim CEO Update Shareholder Letter

Jun 30, 2025, 8:01 AM EDT - 5 months ago

NextPlat Issues Interim CEO Update Shareholder Letter

NXPL

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

Jun 25, 2025, 11:00 AM EDT - 5 months ago

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

OPKO Health to Participate in Two Upcoming Investor Conferences

May 15, 2025, 8:00 AM EDT - 7 months ago

OPKO Health to Participate in Two Upcoming Investor Conferences

OPKO Health, Inc. (OPK) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 7:52 PM EDT - 7 months ago

OPKO Health, Inc. (OPK) Q1 2025 Earnings Call Transcript

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

Apr 4, 2025, 8:00 AM EDT - 8 months ago

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

OPKO and Entera partner to develop obesity pill

Mar 17, 2025, 8:57 AM EDT - 9 months ago

OPKO and Entera partner to develop obesity pill

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Mar 11, 2025, 7:00 AM EDT - 9 months ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

LH

OPKO Health, Inc. (OPK) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:12 PM EST - 10 months ago

OPKO Health, Inc. (OPK) Q4 2024 Earnings Call Transcript

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

Feb 27, 2025, 4:10 PM EST - 10 months ago

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 9, 2025, 11:45 AM EST - 11 months ago

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

Nov 18, 2024, 8:00 AM EST - 1 year ago

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

NXPL

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

Nov 14, 2024, 6:00 AM EST - 1 year ago

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

BABA NXPL

OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript

Nov 7, 2024, 8:30 PM EST - 1 year ago

OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

Oct 7, 2024, 8:00 AM EDT - 1 year ago

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan

Oct 7, 2024, 8:00 AM EDT - 1 year ago

NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan

NXPL

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

Sep 16, 2024, 7:30 AM EDT - 1 year ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

LH

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

Aug 7, 2024, 4:06 PM EDT - 1 year ago

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share Payments

Jul 17, 2024, 4:14 PM EDT - 1 year ago

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share Payments

OPKO Health to Participate in the Jefferies Global Healthcare Conference

May 31, 2024, 10:48 AM EDT - 1 year ago

OPKO Health to Participate in the Jefferies Global Healthcare Conference

OPKO Health, Inc. (OPK) Q1 2024 Earnings Call Transcript

May 7, 2024, 8:03 PM EDT - 1 year ago

OPKO Health, Inc. (OPK) Q1 2024 Earnings Call Transcript

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

May 7, 2024, 4:05 PM EDT - 1 year ago

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

May 3, 2024, 8:00 AM EDT - 1 year ago

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

Mar 28, 2024, 8:00 AM EDT - 1 year ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

LH

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

Mar 5, 2024, 8:52 AM EST - 1 year ago

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 8:08 PM EST - 1 year ago

OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

Feb 27, 2024, 4:05 PM EST - 1 year ago

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

Feb 22, 2024, 4:05 PM EST - 1 year ago

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser's Option to Purchase Additional Notes

Jan 9, 2024, 4:05 PM EST - 2 years ago

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser's Option to Purchase Additional Notes

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

Jan 4, 2024, 11:31 PM EST - 2 years ago

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029

Jan 3, 2024, 5:05 PM EST - 2 years ago

OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

Nov 28, 2023, 7:00 AM EST - 2 years ago

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

Nov 7, 2023, 6:45 AM EST - 2 years ago

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

SOPH

OPKO Health, Inc. (OPK) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 7:32 PM EST - 2 years ago

OPKO Health, Inc. (OPK) Q3 2023 Earnings Call Transcript

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

Nov 6, 2023, 4:05 PM EST - 2 years ago

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

New Clinical Data on OPKO Health's RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

Nov 2, 2023, 10:00 AM EDT - 2 years ago

New Clinical Data on OPKO Health's RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

Oct 31, 2023, 8:00 AM EDT - 2 years ago

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

Oct 25, 2023, 4:25 PM EDT - 2 years ago

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

OPKO Health: FDA Approval To Save The Company

Oct 20, 2023, 1:30 PM EDT - 2 years ago

OPKO Health: FDA Approval To Save The Company

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

Sep 28, 2023, 4:08 PM EDT - 2 years ago

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

OPKO Health, Inc. (OPK) Q2 2023 Earnings Call Transcript

Aug 4, 2023, 12:17 AM EDT - 2 years ago

OPKO Health, Inc. (OPK) Q2 2023 Earnings Call Transcript

OPKO Health: Improving Profitability Should Drive Shares Forward Post Q2 Earnings

Jul 31, 2023, 2:19 PM EDT - 2 years ago

OPKO Health: Improving Profitability Should Drive Shares Forward Post Q2 Earnings

OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023

Jul 25, 2023, 4:05 PM EDT - 2 years ago

OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023

Iightning
Iightning Dec. 5 at 5:22 AM
1ightning® Premium Options Alert (Actionable) Ticker: $OPK Contract: Dec 19 $0.5C Entry: 0.90 Exit: 1.54 Return: +70.81% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 4 at 11:10 PM
1ightning® Premium Options Alert (Actionable) Ticker: $OPK Contract: Dec 19 $0.5C Entry: 0.90 Exit: 1.54 Return: +70.81% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
magadog
magadog Dec. 4 at 8:42 PM
$OPK I predict they will find sone way to restructure the co, sell pieces or all and give the shareholders pennies on the dollar
0 · Reply
Sierradude
Sierradude Dec. 4 at 3:00 PM
$OPK So much for the bullshit presentation. I seriously wonder what the floor is for the tutes to bail? Just get this POS to 2 and I'll take the loss and move on. Dead money for years. Will be interesting to see the market response when the old man croaks.
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 4 at 1:10 PM
$OPK 4 markets last mesage
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 4 at 1:10 PM
$OPK need this 1.35 *
0 · Reply
Mike18181
Mike18181 Dec. 4 at 12:56 PM
$OPK Stock will do " Norhing", the Mirage continues. Stocks rise on earnings. Not buying, by Frost Mirage or buyback mirage. Do you know what a Mirage is ? Do you ? That puddle of water is not really there. And Opko is really casfflow broke. This is why they sold assets to GET CASH. Because they cant retain any !
0 · Reply
Iightning
Iightning Dec. 4 at 6:50 AM
1ightning® Premium Options Alert (Actionable) Ticker: $OPK Contract: Dec 19 $0.5C Entry: 0.90 Exit: 1.70 Return: +88.76% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
magadog
magadog Dec. 3 at 9:00 PM
$OPK
0 · Reply
tradertrash
tradertrash Dec. 3 at 6:51 PM
$OPK annouce a buyback over a year ago, then dilution,
0 · Reply
tymtested
tymtested Dec. 3 at 5:59 PM
$OPK https://d1io3yog0oux5.cloudfront.net/_9427265d2f00c9682f3710af4ce702e3/opko/db/434/4864/pdf/1125_OPKO+corporate+presentation_vF.pdf
1 · Reply
tymtested
tymtested Dec. 3 at 5:48 PM
$OPK A Fidelity Equity Summary Score of 7.1 places OPKO in roughly the top 30–35% of all rated stocks. In other words, about one‑third of the 1,500 largest stocks covered by Fidelity’s StarMine model carry an equivalent or higher rating
0 · Reply
Liorkd
Liorkd Dec. 3 at 5:04 PM
$OPK new presentation available the website
1 · Reply
tradertrash
tradertrash Dec. 3 at 3:40 PM
$OPK nothing like being a sh here and being forgotten by mgt while they enrich and take care of themselves, ZERO fiduciary duty
1 · Reply
tymtested
tymtested Dec. 3 at 1:44 PM
$OPK institutions hold a large portion of Opk, so Opko must convince them first.
0 · Reply
Iightning
Iightning Dec. 3 at 10:18 AM
1ightning® Premium Options Alert (Actionable) Ticker: $OPK Contract: Dec 19 $0.5C Entry: 0.90 Exit: 1.54 Return: +71.11% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
tymtested
tymtested Dec. 2 at 8:16 PM
$OPK
0 · Reply
tymtested
tymtested Dec. 2 at 8:07 PM
$OPK ENTERA and OPKO are both presenting tomorrow.. could be interesting.
1 · Reply
Iightning
Iightning Dec. 2 at 1:09 AM
**1ightning® Premium Options Alert (Actionable)** **Ticker:** $OPK **Contract:** Dec 19 $1C **Entry:** 0.34 **Exit:** 0.59 **Return:** **+74.07% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**
0 · Reply
Sierradude
Sierradude Dec. 1 at 11:10 PM
$OPK This POS is actually in a position for penny swing trading...unfortunately those of us that got screwed by the FDA refusal of SOMA are going to be waiting until we're Frost age to break even. This will be lucky to see 2 by the end of 26.
1 · Reply
tymtested
tymtested Dec. 1 at 5:50 PM
$OPK And dont forget, the stock buyback program and Frosts ongoing purchases continue to reduce the effective float!!
1 · Reply
tymtested
tymtested Dec. 1 at 5:48 PM
$OPK VERY BULLISH!! Consider this: 693M outstanding share - 370M held by Frost and other insiders - 175M held by institutions = 148M effective float(truly tradeable shares); once investors become excited , this stock will soar!!
0 · Reply